Xylem (XYL) Stock Coverage Initiated with Overweight Rating by JP Morgan | XYL Stock News

Author's Avatar
May 30, 2025
Article's Main Image

On May 30, 2025, JP Morgan analyst Mark Strouse initiated coverage on Xylem (XYL, Financial) with an "Overweight" rating. This indicates confidence in the growth prospects of the company, which operates within the water technology sector.

In line with this new rating, JP Morgan has announced a price target of USD 148.00 for Xylem (XYL, Financial). This price target suggests potential upward movement from its current market valuations.

Investors may find this rating initiation by JP Morgan as a significant indicator, considering the firm’s influence and analytical reputation in the financial industry.

Wall Street Analysts Forecast

1928438227459534848.png

Based on the one-year price targets offered by 14 analysts, the average target price for Xylem Inc (XYL, Financial) is $139.23 with a high estimate of $164.00 and a low estimate of $118.21. The average target implies an upside of 10.80% from the current price of $125.66. More detailed estimate data can be found on the Xylem Inc (XYL) Forecast page.

Based on the consensus recommendation from 22 brokerage firms, Xylem Inc's (XYL, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.

Based on GuruFocus estimates, the estimated GF Value for Xylem Inc (XYL, Financial) in one year is $127.36, suggesting a upside of 1.35% from the current price of $125.66. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Xylem Inc (XYL) Summary page.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.